Skip to main content

Advertisement

Log in

Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Retinal excitotoxicity is one of the major causes of retinal ganglion cell (RGC) death in glaucoma. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic peptide with potent neuroprotective activity; however, whether it exerts such an effect in the retina and the mechanism by which RGCs are protected is still not well understood. In this study, we examined the effect of exogenous and endogenous PACAP on RGC death induced by N-methyl-d-aspartate acid (NMDA). The vitreous body of anesthetized adult male mice (C57/BL6J) was injected with NMDA (40 nmol in a 2 μL saline solution). The number of RGCs decreased from days 1 to 7 after NMDA injection, and the number of dUTP end-labeling (TUNEL)-positive cells, an indicator of cell death, peaked at day 3. However, when PACAP38 (10−8, 10−10, 10−12, 10−14, or 10−16M) was co-administered with NMDA, the 10−10M dose resulted in significantly increased RGC survival at day 7, and a decrease in the number of TUNEL-positive RGCs at day 3. We next investigated the neuroprotective effect of endogenous PACAP using PACAP heterozygote(+/−) mice. Under normal circumstances, there was no significant difference in the number of RGCs in the PACAP(+/−) mice compared with their wild-type counterparts. However, the number of RGCs significantly decreased in the PACAP(+/−) mice 7 days after NMDA injection, relative to their wild-type counterparts. The number of TUNEL-positive RGCs peaked at day 1 in the PACAP(+/−) mice. These effects in the PACAP(+/−) mice were reversed by intravitreous injection of 10−10M PACAP38. This suggests that exogenous PACAP is able to counteract NMDA-induced toxicity, and that endogenous PACAP exerts a neuroprotective effect in the retina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301–331

    Article  CAS  PubMed  Google Scholar 

  • Arimura A, Shioda S (1995) Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 16:53–88

    Article  CAS  PubMed  Google Scholar 

  • Atlasz T, Szabadfi K, Reglodi D et al (2009) Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment. Ann NY Acad Sci 1163:348–352

    Article  CAS  PubMed  Google Scholar 

  • Atlasz T, Szabadfi K, Kiss P et al (2010) Evaluation of the protective effects of PACAP with cell-specific marlers in ischemia-induced retinal degeneration. Brain Res Bull 81:497–504

    Article  CAS  PubMed  Google Scholar 

  • Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE (1997) Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res 58:864–867

    CAS  PubMed  Google Scholar 

  • Dkhissi O, Chanut E, Wasowicz M, Savoldelli M, Nguyen-Legros J, Minvielle F, Versaux-Botteri C (1999) Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 40:990–995

    CAS  PubMed  Google Scholar 

  • Hare WA, Wheeler L (2009) Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine. Invest Ophthalmol Vis Sci 50:2940–2948

    Article  PubMed  Google Scholar 

  • Hashimoto H, Shintani N, Tanaka K et al (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355–13360

    Article  CAS  PubMed  Google Scholar 

  • Kido N, Tanihara H, Honjo M, Inatani M, Tatsuno T, Nakayama C, Honda Y (2000) Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death. Brain Res 884:59–67

    Article  CAS  PubMed  Google Scholar 

  • Lam TT, Abler AS, Kwong JM, Tso MO (1999) N-methyl-d-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 40:2391–2397

    CAS  PubMed  Google Scholar 

  • Li M, David C, Kikuta T, Somogyvari-Vigh A, Arimura A (2005) Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. J Mol Neurosci 27:91–105

    Article  PubMed  Google Scholar 

  • Liu GJ, Madsen BW (1997) PACAP38 modulates activity of NMDA receptors in cultured chick cortical neurons. J Neurophysiol 78:2231–2234

    CAS  PubMed  Google Scholar 

  • Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, Funahashi H, Matsuda K, Shioda S (2005) Orexin-1 receptor expression after global ischemia in mice. Regul Pept 126:49–54

    Article  CAS  PubMed  Google Scholar 

  • Nakamachi T, Li M, Shioda S, Arimura A (2006) Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression. Peptides 27:1859–1864

    Article  CAS  PubMed  Google Scholar 

  • Ohtaki H, Nakamachi T, Dohi K, Aizawa Y, Takaki A, Hodoyama K, Yofu S, Hashimoto H, Shintani N, Baba A, Kopf M, Iwakura Y, Matsuda K, Arimura A, Shioda S (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci USA 103:7488–7493

    Article  CAS  PubMed  Google Scholar 

  • Quigley HA (1995) Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 23:85–91

    Article  CAS  PubMed  Google Scholar 

  • Racz B, Gallyas F Jr, Kiss P et al (2006) The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways. Regul Pept 137:20–26

    Article  CAS  PubMed  Google Scholar 

  • Racz B, Gallyas F Jr, Kiss P et al (2007) Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-BAD-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rat. Neurotox Res 12(2):95–104

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Shioda S, Ogino D, Nakai Y, Arimura A, Koide R (1997) Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina. Neurosci Lett 238:127–130

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Shioda S, Nakai Y, Arimura A, Koide R (1998) Distribution and ultrastructural localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor in the rat retina. Ann NY Acad Sci 865:408–411

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Izumi S, Shioda S, Zhou CJ, Arimura A, Koide R (2000a) Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR. Ann NY Acad Sci 921:366–369

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Shioda S, Izumi S, Arimura A, Koide R (2000b) Electron microscopic observation of pituitary adenylate cyclase-activating polypeptide (PACAP)-containing neurons in the rat retina. Peptides 21:109–113

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Nakatani M, Taki C, Shinohara Y, Ozawa M, Nishimura S, Ito H, Shioda S (2006) Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina. Ann NY Acad Sci 1070:531–534

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Itoh H, Nakamachi T, Shioda S (2008) Suppression of ganglion cell death by PACAP following optic nerve transection in the rat. J Mol Neurosci 36:57–60

    Article  CAS  PubMed  Google Scholar 

  • Seki T, Itoh H, Nakamachi T, Endo K, Waday, Nakamura K, Shioda S (2010) Suppression of rat retinal ganglion cell death by PACAP following transient ischemia induced by high intraocular pressure. J Mol Neurosci (in press)

  • Sherwood NM, Krueckl SL, McRory JE (2000) The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619–670

    Article  CAS  PubMed  Google Scholar 

  • Shintani N, Suetake S, Hashimoto H, Koga K, Kasai A, Kawaguchi C, Morita Y, Hirose M, Sakai Y, Tomimoto S, Matsuda T, Baba A (2005) Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul Pept 126:123–128

    Article  CAS  PubMed  Google Scholar 

  • Shioda S, Ohtaki H, Nakamachi T, Dohi K, Watanabe J, Nakajo S, Arata S, Kitamura S, Okuda H, Takenoya F, Kitamura Y (2006) Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann NY Acad Sci 1070:550–560

    Article  CAS  PubMed  Google Scholar 

  • Sucher NJ, Aizenman E, Lipton SA (1991) N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci 11:966–971

    CAS  PubMed  Google Scholar 

  • Tamas A, Gabriel R, Racz B, Denes V, Kiss P, Lubics A, Lengvari I, Reglodi D (2004) Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate. Neurosci Lett 372:110–113

    Article  CAS  PubMed  Google Scholar 

  • Teuchner B, Dimmer A, Humpel C et al (2010) VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina. Acta Ophthalmol (in press)

  • Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S, Banks WA (1996) Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 736:280–286

    Article  CAS  PubMed  Google Scholar 

  • Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fournier A, Vaudry H (2000) PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex. Ann NY Acad Sci 921:293–299

    Article  CAS  PubMed  Google Scholar 

  • Vaudry D, Hamelink C, Damadzic R, Eskay RL, Gonzalez B, Eiden LE (2005) Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides 26:2518–2524

    Article  CAS  PubMed  Google Scholar 

  • Varga B, Szabadfi K, Kiss P et al (2010) PACAP Improves Functional Outcome in Excitotoxic Retinal Lesion: An Electroretinographic Study. J Mol Neurosci. (in press)

  • Yaka R, He DY, Phamluong K, Ron D (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP (1–38)) enhances N-methyl-d-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J Biol Chem 278:9630–9638

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by the Ministry of Education, Science, Sports and Culture of Japan and in part by a High-Technology Research Center Project from the Ministry of Education, Science, Sports and Culture of Japan (T.S., T.N., S.S.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seiji Shioda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endo, K., Nakamachi, T., Seki, T. et al. Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse. J Mol Neurosci 43, 22–29 (2011). https://doi.org/10.1007/s12031-010-9434-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-010-9434-x

Keywords

Navigation